Cargando…
miR-448 targets Rab2B and is pivotal in the suppression of pancreatic cancer
Improvements in survival rates for pancreatic cancer have been slow and the morality rate continues to increase in patients. MicroRNA (miR)-448 is reported to be significantly downregulated in several types of cancer. In this study, Rab2B is target of miR-488 was confirmed by bioinformatics analysis...
Autores principales: | Jin, Jing, Wu, Yingsheng, Zhou, Dongkai, Sun, Qiang, Wang, Weilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072403/ https://www.ncbi.nlm.nih.gov/pubmed/30015954 http://dx.doi.org/10.3892/or.2018.6562 |
Ejemplares similares
-
The antitumor effect of miR-448 in epithelial ovarian cancer
por: Li, Tao, et al.
Publicado: (2020) -
MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B
por: Hong, Xuehui, et al.
Publicado: (2016) -
miR-448 targets IDO1 and regulates CD8(+) T cell response in human colon cancer
por: Lou, Qiong, et al.
Publicado: (2019) -
Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma
por: Wei, Hui, et al.
Publicado: (2020) -
LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer
by Targeting ZEB1 via miR-448
por: Wu, Hanquan, et al.
Publicado: (2022)